85 related articles for article (PubMed ID: 26692443)
1. Increased Expression of the Glucose Transporter Type 1 Gene Is Associated With Worse Overall Survival in Resected Pancreatic Adenocarcinoma.
Davis-Yadley AH; Abbott AM; Pimiento JM; Chen DT; Malafa MP
Pancreas; 2016 Aug; 45(7):974-9. PubMed ID: 26692443
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of glucose transporter-1 in pancreatic cancer.
Lu K; Yang J; Li DC; He SB; Zhu DM; Zhang LF; Zhang XU; Chen XC; Zhang B; Zhou J
Oncol Lett; 2016 Jul; 12(1):243-249. PubMed ID: 27347132
[TBL] [Abstract][Full Text] [Related]
3. GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: immunohistochemistry study showing the correlation between expression and survival.
Achalandabaso Boira M; Di Martino M; Gordillo C; Adrados M; Martín-Pérez E
BMC Cancer; 2020 Sep; 20(1):909. PubMed ID: 32967636
[TBL] [Abstract][Full Text] [Related]
4. Bitter melon juice-intake modulates glucose metabolism and lactate efflux in tumors in its efficacy against pancreatic cancer.
Dhar D; Raina K; Kant R; Wempe MF; Serkova NJ; Agarwal C; Agarwal R
Carcinogenesis; 2019 Sep; 40(9):1164-1176. PubMed ID: 31194859
[TBL] [Abstract][Full Text] [Related]
5. Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.
Chikamoto A; Inoue R; Komohara Y; Sakamaki K; Hashimoto D; Shiraishi S; Takamori H; Yamashita YI; Yoshida N; Yamanaka T; Yamashita Y; Baba H
Ann Surg Oncol; 2017 Jul; 24(7):2040-2046. PubMed ID: 28180987
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients.
Sharen G; Peng Y; Cheng H; Liu Y; Shi Y; Zhao J
Oncotarget; 2017 Mar; 8(12):19760-19767. PubMed ID: 28178665
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.
Reske SN; Grillenberger KG; Glatting G; Port M; Hildebrandt M; Gansauge F; Beger HG
J Nucl Med; 1997 Sep; 38(9):1344-8. PubMed ID: 9293784
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis-related factors are relevant to progression of pancreatic neuroendocrine tumors.
Amano S; Hirashita T; Kawano Y; Nishida H; Orimoto H; Kawamura M; Kawasaki T; Masuda T; Endo Y; Ohta M; Daa T; Inomata M
World J Surg Oncol; 2023 Dec; 21(1):381. PubMed ID: 38082268
[TBL] [Abstract][Full Text] [Related]
9. The Interplay between T Cells and Cancer: The Basis of Immunotherapy.
Chen C; Liu X; Chang CY; Wang HY; Wang RF
Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239368
[TBL] [Abstract][Full Text] [Related]
10. GLUT-1 may predict metastases and death in patients with locally advanced rectal cancer.
Kim TH; Kwak Y; Song C; Lee HS; Kim DW; Oh HK; Kim JW; Lee KW; Kang SB; Kim JS
Front Oncol; 2023; 13():1094480. PubMed ID: 36968998
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis.
Amrutkar M; Berg K; Balto A; Skilbrei MG; Finstadsveen AV; Aasrum M; Gladhaug IP; Verbeke CS
Cancer Cell Int; 2023 Jan; 23(1):9. PubMed ID: 36658582
[TBL] [Abstract][Full Text] [Related]
12. Orchestration of mesenchymal plasticity and immune evasiveness
Hashimoto A; Handa H; Hata S; Hashimoto S
Front Oncol; 2022; 12():1005566. PubMed ID: 36408139
[TBL] [Abstract][Full Text] [Related]
13. Relationships between expression of glucose transporter protein-1 and hypoxia inducible factor-1α, prognosis and
Shen LF; Zhou SH; Yu Q
Transl Cancer Res; 2020 Apr; 9(4):2824-2837. PubMed ID: 35117639
[TBL] [Abstract][Full Text] [Related]
14. Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches.
Carvalho TMA; Di Molfetta D; Greco MR; Koltai T; Alfarouk KO; Reshkin SJ; Cardone RA
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885243
[TBL] [Abstract][Full Text] [Related]
15. Glioma Stem-Like Cells and Metabolism: Potential for Novel Therapeutic Strategies.
Harland A; Liu X; Ghirardello M; Galan MC; Perks CM; Kurian KM
Front Oncol; 2021; 11():743814. PubMed ID: 34532295
[TBL] [Abstract][Full Text] [Related]
16. Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer.
Tilekar K; Upadhyay N; Iancu CV; Pokrovsky V; Choe JY; Ramaa CS
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188457. PubMed ID: 33096154
[TBL] [Abstract][Full Text] [Related]
17. S6 ribosomal protein phosphorylation is associated with malignancy of intraductal papillary mucinous neoplasm of the pancreas.
Hirashita T; Hirashita Y; Iwashita Y; Endo Y; Kiyonaga M; Matsumoto S; Hijiya N; Moriyama M; Murakami K; Inomata M
Ann Gastroenterol Surg; 2020 Sep; 4(5):571-579. PubMed ID: 33005852
[TBL] [Abstract][Full Text] [Related]
18. Lactate in Sarcoma Microenvironment: Much More than just a Waste Product.
Taddei ML; Pietrovito L; Leo A; Chiarugi P
Cells; 2020 Feb; 9(2):. PubMed ID: 32102348
[TBL] [Abstract][Full Text] [Related]
19. Vascular lesions of the head and neck: an update on classification and imaging review.
Brahmbhatt AN; Skalski KA; Bhatt AA
Insights Imaging; 2020 Feb; 11(1):19. PubMed ID: 32034537
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
